The final outcomes of company requests for relief from next April's catch-up statutory price reductions have been delayed pending a final assessment by the office of health minister Mark Butler. …
Ministerial intervention in final outcomes as concern grows over patient impact
November 21, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Companies secure certification as 'Great Places to Work'
July 23, 2025 - - Latest News -
US leads the way on cell and gene therapy with new rapid access program
July 23, 2025 - - Latest News -
Neuraxpharm continues international expansion with launch of Australian affiliate
July 23, 2025 - - Latest News -
Pharmac minister asks for more in new letter of expectations
July 23, 2025 - - Latest News -
Sarepta backs down on FDA demand to halt distribution of gene therapy
July 22, 2025 - - Latest News -
Some of Pharmac's fiercest critics appointed to guide its 'reset' program
July 22, 2025 - - Latest News -
Mark Butler acknowledges dubious relationship between the PBS and US tariffs
July 22, 2025 - - Latest News